Credit Suisse Sets Outperform Rating, $125 Target On Gilead Story By: Benzinga via Benzinga January 20, 2016 at 08:26 AM EST Gilead Sciences, Inc. (NASDAQ: GILD) share are down 11 percent since January 4. Credit Suisse’s Alethia Young ... Read More >> Related Stocks: Gilead Sciences Merck & Co